查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439342

眼科黏彈性器材 (OVD) - 全球市場考量、競爭格局、市場預測 (2030)

Ophthalmic Viscoelastic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2023年全球眼科黏彈性器械（OVD）市場規模將達25億美元，到2030年將達到32.1億美元，2024-2030年預測期間複合年增長率為4.23%。由於白內障和青光眼等眼病患病率上升、技術進步以及人口老化迅速增加，預計該市場將會成長。

眼科黏彈性器材 (OVD) 市場動態

眼科黏彈性裝置（OVD）市場已顯著擴大，因為它多年來一直用於眼內手術以保護眼睛內的脆弱結構。這些設備的使用對白內障手術、青光眼手術和玻璃體視網膜手術等手術具有重大意義。根據世界衛生組織（WHO）2022年的統計，至少有22億人有近視或遠視。在全球範圍內，這些人中至少有 10 億（幾乎一半）患有可預防或未經治療的視力喪失。視力喪失和失明的主要原因是未矯正的白內障。因此，眼科疾病和手術患者的快速增加正在促進全球眼科黏彈性裝置（OVD）市場的成長。

此外，新技術的進步也達到了一個高峰。例如，2022年4月，Bausch + Lomb宣佈美國食品藥物管理局（FDA）已批准其ClearVisc™可分散眼科黏彈性裝置（OVD）用於眼科手術。該裝置在眼科手術期間可以非常有效地保護角膜。眼科黏彈性器械（OVD）領域的此類技術進步可能會推動全球眼科黏彈性器械（OVD）市場的發展。

此外，根據《世界人口展望World Population Prospects（2019）》，2019年全球65歲以上人口為7.03億。此外，根據最近的一項研究《2020年全球人口老化報告Global Population Aging 2020 Report》（聯合國，2020），人口老化正以驚人的速度成長。2020年，全球65歲以上人口約為7.27億人。到 2050 年，此類患者的數量預計將增加一倍，達到 15 億。因此，隨著老年人口的增加，老年人眼睛患白內障的可能性也會增加，這反過來又促進了全球眼科黏彈性裝置（OVD）市場的成長。

除上述因素外，由於為遏制 COVID-19 傳播而實施的封鎖措施，眼科黏彈性器械 (OVD) 市場經歷了暫時的衰退。這段時間的主要措施之一是暫停許多擇期手術和門診。受此影響，封城初期各醫療科室大量手術暫停，導致市場對眼科黏彈器械（OVD）的需求減少，從而短期限制了市場成長。話雖如此，眼科黏彈性器材（OVD）市場正處於復甦階段，由於世界各地多種 COVID-19 疫苗的批准和管理，包括醫療保健服務在內的各個領域的活動都已恢復。

眼科黏彈性器材 (OVD) 細分市場分析

以眼科黏彈性器械（OVD）市場的類型細分，複合眼科黏彈性器械細分市場預計將佔據全球眼科黏彈性器械（OVD）市場的主要份額。該產品領域的巨大市場份額歸因於越來越多的患者採用這些設備。

眼科黏彈性材料可以具有分散性和內聚性。在手術過程中，保護角膜內皮是一種分散特性，在囊膜脫離過程中壓平水晶體前囊是一種內聚特性。對於許多外科醫生來說，使用複合眼科黏彈性材料可以兩全其美，因為它們可以用作整個手術的專用黏彈性材料。此類藥物的例子包括 DiscoVisc (Alcon) 和 Amvisc Plus (B&L)，這兩種藥物都旨在成為適合常規病例的單注射藥物。

本報告提供了全球眼科黏彈性器材（OVD）市場的研究和分析，包括市場規模和預測、驅動因素和挑戰、公司和產品概況。

目錄

第一章眼科黏彈性裝置（OVD）市場報告簡介

第二章眼科黏彈性器材 (OVD) 市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估
  • 財務基準

第三章 法規與專利分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章眼科黏彈器材（OVD）市場關鍵因素分析

  • 眼科黏彈性器械 (OVD) 市場驅動因素
    • 眼科疾病盛行率上升
    • 老年人口快速增加
    • 技術進步
  • 眼科黏彈性裝置 (OVD) 的限制與挑戰
    • 手術後移除 OVD 的相關風險
    • 術後併發症
  • 眼科黏彈性裝置 (OVD) 的機遇
    • 人們越來越偏愛先進設備
    • 新興國家的增長機會

第 5 章眼科黏彈性裝置 (OVD) 的波特五力分析

第六章 COVID-19對眼科黏彈性器材（OVD）市場的影響分析

第七章 眼科黏彈器械（OVD）市場佈局

  • 按類型
    • 黏性眼科黏彈性
    • 可分散眼科黏彈性
    • 複合材料眼科黏彈性
    • 黏度自適應眼科黏彈性
  • 按用途
    • 白內障手術
    • 青光眼手術
    • 角膜移植
    • 玻璃體視網膜手術
  • 按最終用戶
    • 醫院
    • 眼科診所
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第 8 章 眼科黏彈性器材 (OVD)：全球公司份額分析 - 3 至 5 家主要公司

第九章 眼科黏彈器械（OVD）公司及產品簡介

  • Bausch Health Companies Inc.
  • Eyekon Medical Inc.
  • Bohus BioTech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Alcon Inc.
  • Rumex International Corporation
  • Altacor
  • Ophtechnics Unlimited
  • Beaver Visitec Limited
  • PhysIOL
  • Neu Micromed International Pvt. Ltd.
  • Rayner Intraocular Lenses Limited
  • Aurolab
  • Abbott Medical Optics
  • Maxigen Biotech Inc.
  • Amring Pharmaceuticals Inc.
  • Sight Sciences, Inc.
  • Anika Therapeutics, Inc.

第10章 項目方法

  • 二次資料
  • 一次資料
  • 數據三角測量
  • 主要專家意見

第11章 KOL觀點

第12章 DelveInsight服務內容

第13章 免責聲明

第 14 章關於 DelveInsight

Product Code: DIMDCL0134

Ophthalmic Viscoelastic Devices Market By Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, Visco-Adaptive Ophthalmic Viscoelastic), By Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, Others), And By End-User (Hospitals, Ophthalmology Clinics, Others), by geography, is expected to grow at a steady CAGR forecast till 2030 owing to the technological advancements and surge in the geriatric population

Global Ophthalmic Viscoelastic Devices Market was valued at USD 2.50 billion in 2023, growing at a CAGR of 4.23% during the forecast period from 2024 to 2030, to reach USD 3.21 billion by 2030. The Ophthalmic Viscoelastic Devices market is expected to witness growth due to the rising prevalence of ophthalmic conditions like cataracts, glaucoma, and others, technological advancements, and the surge in the geriatric population.

Ophthalmic Viscoelastic Devices Market Dynamics:

Ophthalmic Viscoelastic Devices (OVDs) Market has significantly increased due to the fact that for many years, Ophthalmic Viscoelastic Devices have been used in intraocular surgery to protect delicate structures inside the eyes. The use of these devices has major significance during procedures like cataract surgeries, glaucoma surgeries, vitreoretinal surgeries. As per World Health Organization 2022, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion - or almost half - of these cases, vision impairment could have been prevented or has yet to be addressed globally. The leading causes of vision impairment and blindness are uncorrected cataracts. Thus, the burgeoning cases of ophthalmic conditions and surgeries will contribute to the Global Ophthalmic Viscoelastic Devices Market growth.

In addition, the advancement of new technologies is advancing at a great peak. For instance, in April 2022, Bausch + Lomb announced that the US Food and Drug Administration (FDA) approved ClearVisc(TM) dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. The device offers exceptional corneal protection during ophthalmic surgery. Such technological advancement in the field of Ophthalmic Viscoelastic Devices is likely to boost the Global Ophthalmic Viscoelastic Devices Market.

Furthermore, as per the World Population Prospects, 2019, there were 703 million older persons aged 65 or over in 2019 globally. Moreover, as per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure for such patients is expected to double and reach 1.5 billion by 2050. Therefore, as the aging population increases, there will be more chances of the older population getting cataracts in their eyes, which will eventually boost the growth of the Global Ophthalmic Viscoelastic Devices market.

Along with the above-mentioned factors, the Ophthalmic Viscoelastic Devices market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Ophthalmic Viscoelastic Devices in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for Ophthalmic Viscoelastic Devices is in the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Ophthalmic Viscoelastic Devices market during the forecast period.

Ophthalmic Viscoelastic Devices Market Segment Analysis:

Ophthalmic Viscoelastic Devices Market By Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, Visco-Adaptive Ophthalmic Viscoelastic), by Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, Others), Ophthalmic Viscoelastic Devices Market by End-User (Hospitals, Ophthalmology Clinics, Others), and Ophthalmic Viscoelastic Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Ophthalmic Viscoelastic Devices market tye segment, the Combination Ophthalmic Viscoelastic market segment will hold the major share of the Global Ophthalmic Viscoelastic Devices market. The large market share of this product segment can be attributed to the growing patient adoption of these devices.

Combination Ophthalmic Viscoelastic may have some dispersive properties as well as some cohesive properties. Protecting the corneal endothelium throughout the surgery is a dispersive characteristic while flattening the anterior lens capsule during capsulorhexis is a cohesive attribute. For many surgeons, using a Combination of Ophthalmic Viscoelastic has the best of both as they can use it as the exclusive viscoelastic for the entire surgery. Examples of these agents include DiscoVisc (Alcon) and Amvisc Plus (B&L), both of which aim to be good single-syringe agents for routine cases.

Realizing that two separate OVDs offer more versatility than a single agent, companies offer dual-viscoelastic systems, which incorporate a dispersive OVD and a cohesive OVD in separate syringes which are known as Dual OVD Packages. These can be opened together, though they are not packaged as such.

Therefore, Combination Ophthalmic Viscoelastic Devices are gaining commercial acceptability, which improves market penetration. All these advantages of these devices make physicians more inclined to use Combination Ophthalmic Viscoelastic.

Hence, all the above-mentioned factors are expected to drive the segment growth of the Ophthalmic Viscoelastic Devices market.

North America is expected to dominate the overall Global Ophthalmic Viscoelastic Devices Market:

North America is expected to dominate the overall Ophthalmic Viscoelastic Devices market during the forecast period. This domination is due to the rising number of cataract surgeries, and other ophthalmic surgeries in the region. As per the Journal of Cataract Refract Surgeries 2020, the volume of cataract surgeries performed per year has increased steadily over the past few decades in the United States.

Additionally, according to Cancer Vision 2020, based on the trends in the surgical volume of cataract surgery over the past decade, 3.7 million cataract cases would have been performed in 2020 in the United States among Medicare beneficiaries. Thus, the burgeoning cases of cataract surgeries will contribute to the growth of the Ophthalmic Viscoelastic Devices Market in the region as the demand will increase.

Further, in North America, the market is supported by developed healthcare infrastructure and strong adoption of technologically advanced products owing to the rise in healthcare expenditure by the government and increase prevalence and incidence of surgeries as mentioned above.

Europe and Asia-Pacific region have the future potential growth for the Global Ophthalmic Viscoelastic Devices market. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Ophthalmic Viscoelastic Devices market. For instance, in May 2020 BVI announced the acquisition of the ophthalmic viscoelastic device (OVD) assets from Croma, an Austrian-based company. In addition to the acquisition of existing products, BVI and Croma have embarked on an R&D collaboration on additional products that will come to market in the future. Such initiatives are anticipated to boost the Ophthalmic Viscoelastic Devices Market.

Ophthalmic Viscoelastic Devices Market Key Players:

Some of the key market players operating in the Global Ophthalmic Viscoelastic Devices Market include Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc., Anika Therapeutics, Inc. among others.

Recent Developmental Activities in the Ophthalmic Viscoelastic Devices Market:

In June 2022, Rayner announced that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. This acquisition helped Rayner to rapidly bring its strong pipeline of innovative intraocular lenses (IOLs), ophthalmic viscoelastic devices (OVDs), and dry eye drop solutions to surgeons and patients across India, and further develop its global presence.

In April 2022, Bausch + Lomb announced that the FDA has approved its ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.

Key Takeaways from the Ophthalmic Viscoelastic Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Ophthalmic Viscoelastic Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Ophthalmic Viscoelastic Devices Market.

Various opportunities are available for the other competitor in the Ophthalmic Viscoelastic Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Ophthalmic Viscoelastic Devices market growth in the coming future?

Target Audience who can be benefited from this Ophthalmic Viscoelastic Devices Market Ket Report Study

Ophthalmic Viscoelastic Devices providers

Research organizations and consulting companies

Ophthalmic Viscoelastic Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Ophthalmic Viscoelastic Devices

Various End-users want to know more about the Ophthalmic Viscoelastic Devices Market and the latest technological developments in the Ophthalmic Viscoelastic Devices market.

Frequently Asked Questions for Ophthalmic Viscoelastic Devices Market:

1. What are Ophthalmic Viscoelastic Devices?

Ophthalmologists use ophthalmic viscoelastic devices (OVDs) in multiple eye operations, such as cataract surgery, glaucoma surgery, among others. These devices help secure the fragile eye structures along with creating pressure in the anterior cavity, compartmentalizing the interior of the eye, and providing patients with faster healing for easier and safer surgery.

2. What is the market for Global Ophthalmic Viscoelastic Devices?

Global Ophthalmic Viscoelastic Devices Market was valued at USD 2.50 billion in 2023, growing at a CAGR of 4.23% during the forecast period from 2024 to 2030, to reach USD 3.21 billion by 2030.

3. What are the drivers for Global Ophthalmic Viscoelastic Devices?

The major drivers driving the demand for Ophthalmic Viscoelastic Devices are the growth due to the rising prevalence of ophthalmic conditions like cataracts, glaucoma, and others, technological advancements, and the surge in the geriatric population.

4. What are the key players operating in Global Ophthalmic Viscoelastic Devices?

Some of the key market players operating in the Ophthalmic Viscoelastic Devices market include Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc. Anika Therapeutics, Inc., and others.

5. What regions have the highest share in the Ophthalmic Viscoelastic Devices market?

North America is expected to dominate the overall global Ophthalmic Viscoelastic Devices market during the forecast period from 2024 to 2030. This domination is due to the rising number of cataract surgeries, and other ophthalmic surgeries in the region.

Table of Contents

1.Ophthalmic Viscoelastic Devices Market Report Introduction

2.Ophthalmic Viscoelastic Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Ophthalmic Viscoelastic Devices Market Key factors analysis

  • 4.1 Ophthalmic Viscoelastic Devices Market Drivers
    • 4.1.1 Rising prevalence of ophthalmic conditions
    • 4.1.2 The surge in geriatric population
    • 4.1.3 Rising technological advancements
  • 4.2 Ophthalmic Viscoelastic Devices Restraints and Challenges
    • 4.2.1 The risk associated with removal of OVDs after surgery
    • 4.2.2 Postoperative complications
  • 4.3 Ophthalmic Viscoelastic Devices Opportunities
    • 4.3.1 Growing preference for advanced devices
    • 4.3.2 Growth opportunities in emerging countries

5. Ophthalmic Viscoelastic Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Ophthalmic Viscoelastic Devices Market

7. Ophthalmic Viscoelastic Devices Market layout

  • 7.1 By Type
    • 7.1.1 Cohesive Ophthalmic Viscoelastic
    • 7.1.2 Dispersive Ophthalmic Viscoelastic
    • 7.1.3 Combination Ophthalmic Viscoelastic
    • 7.1.4 Visco-Adaptive Ophthalmic Viscoelastic
  • 7.2 By Application
    • 7.2.1 Cataract Surgery
    • 7.2.2 Glaucoma Surgery
    • 7.2.3 Corneal Transplantation
    • 7.2.4 Vitreoretinal Surgery
  • 7.3 By End User
    • 7.3.1 Hospitals
    • 7.3.2 Ophthalmology Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.1.2 North America Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.1.3 North America Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.1.4 North America Ophthalmic Viscoelastic Devices Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.2.2 Europe Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.2.3 Europe Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.2.4 Europe Ophthalmic Viscoelastic Devices Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.3.2 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.3.3 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.3.4 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.4.2 RoW Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.4.3 RoW Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.4.4 RoW Ophthalmic Viscoelastic Devices Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Ophthalmic Viscoelastic Devices Global Company Share Analysis - Key 3-5 Companies

9. Ophthalmic Viscoelastic Devices Company and Product Profiles

  • 9.1 Bausch Health Companies Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Eyekon Medical Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Bohus BioTech AB
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Carl Zeiss Meditec AG
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 CIMA Technology Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Johnson & Johnson Vision Care, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Alcon Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Rumex International Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Altacor
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Ophtechnics Unlimited
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Beaver Visitec Limited
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 PhysIOL
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Neu Micromed International Pvt. Ltd.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Rayner Intraocular Lenses Limited
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Aurolab
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Abbott Medical Optics
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Maxigen Biotech Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Amring Pharmaceuticals Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Sight Sciences, Inc.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy Anika Therapeutics, Inc.
  • 9.20 Anika Therapeutics, Inc.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. PROJECT APPROACH

  • 10.1 Secondary Sources
  • 10.2 Primary Sources
  • 10.3 Data Triangulation
  • 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Ophthalmic Viscoelastic Devices Market
  • Table 3 Ophthalmic Viscoelastic Devices Market Analysis in Global (2021-2030)
  • Table 4 Ophthalmic Viscoelastic Devices Market Analysis in Global by Type (2021-2030)
  • Table 5 Ophthalmic Viscoelastic Devices Market Analysis in Global by Application (2021-2030)
  • Table 6 Ophthalmic Viscoelastic Devices Market Analysis in Global by End User (2021-2030)
  • Table 7 Ophthalmic Viscoelastic Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8 Ophthalmic Viscoelastic Devices Market Analysis in North America (2021-2030)
  • Table 9 Ophthalmic Viscoelastic Devices Market Analysis in North America by Type (2021-2030)
  • Table 10 Ophthalmic Viscoelastic Devices Market Analysis in North America by Application (2021-2030)
  • Table 11 Ophthalmic Viscoelastic Devices Market Analysis in North America by End User (2021-2030)
  • Table 12 Ophthalmic Viscoelastic Devices Market Analysis in North America by Country (2021-2030)
  • Table 13 Ophthalmic Viscoelastic Devices Market Analysis in the US (2021-2030)
  • Table 14 Ophthalmic Viscoelastic Devices Market Analysis in Canada (2021-2030)
  • Table 15 Ophthalmic Viscoelastic Devices Market Analysis in Mexico (2021-2030)
  • Table 16 Ophthalmic Viscoelastic Devices Market Analysis in Europe (2021-2030)
  • Table 17 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Type (2021-2030)
  • Table 18 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Application (2021-2030)
  • Table 19 Ophthalmic Viscoelastic Devices Market Analysis in Europe by End User (2021-2030)
  • Table 20 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Country (2021-2030)
  • Table 21 Ophthalmic Viscoelastic Devices Market Analysis in France (2021-2030)
  • Table 22 Ophthalmic Viscoelastic Devices Market Analysis in Germany (2021-2030)
  • Table 23 Ophthalmic Viscoelastic Devices Market Analysis in UK (2021-2030)
  • Table 24 Ophthalmic Viscoelastic Devices Market Analysis in Italy (2021-2030)
  • Table 25 Ophthalmic Viscoelastic Devices Market Analysis in Spain (2021-2030)
  • Table 26 Ophthalmic Viscoelastic Devices Market Analysis in Russia (2021-2030)
  • Table 27 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific (2021-2030)
  • Table 29 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Type (2021-2030)
  • Table 30 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Application (2021-2030)
  • Table 31 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by End User (2021-2030)
  • Table 32 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Country (2021-2030)
  • Table 33 Ophthalmic Viscoelastic Devices Market Analysis in China (2021-2030)
  • Table 34 Ophthalmic Viscoelastic Devices Market Analysis in Japan (2021-2030)
  • Table 35 Ophthalmic Viscoelastic Devices Market Analysis in India (2021-2030)
  • Table 36 Ophthalmic Viscoelastic Devices Market Analysis in Australia (2021-2030)
  • Table 37 Ophthalmic Viscoelastic Devices Market Analysis in South Korea (2021-2030)
  • Table 38 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Asia Pacific (2021-2030)
  • Table 39 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World (2021-2030)
  • Table 40 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Type (2021-2030)
  • Table 41 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Application (2021-2030)
  • Table 42 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by End User (2021-2030)
  • Table 43 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Country (2021-2030)
  • Table 44 Ophthalmic Viscoelastic Devices Market Analysis in Middle East (2021-2030)
  • Table 45 Ophthalmic Viscoelastic Devices Market Analysis in Africa (2021-2030)
  • Table 46 Ophthalmic Viscoelastic Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Ophthalmic Viscoelastic Devices Market
  • Figure 3 Ophthalmic Viscoelastic Devices Market Analysis in Global (2021-2030)
  • Figure 4 Ophthalmic Viscoelastic Devices Market Analysis in Global by Type (2021-2030)
  • Figure 5 Ophthalmic Viscoelastic Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6 Ophthalmic Viscoelastic Devices Market Analysis in Global by End User (2021-2030)
  • Figure 7 Ophthalmic Viscoelastic Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Ophthalmic Viscoelastic Devices Market Analysis in North America (2021-2030)
  • Figure 9 Ophthalmic Viscoelastic Devices Market Analysis in North America by Type (2021-2030)
  • Figure 10 Ophthalmic Viscoelastic Devices Market Analysis in North America by Application (2021-2030)
  • Figure 11 Ophthalmic Viscoelastic Devices Market Analysis in North America by End User (2021-2030)
  • Figure 12 Ophthalmic Viscoelastic Devices Market Analysis in North America by Country (2021-2030)
  • Figure 13 Ophthalmic Viscoelastic Devices Market Analysis in the US (2021-2030)
  • Figure 14 Ophthalmic Viscoelastic Devices Market Analysis in Canada (2021-2030)
  • Figure 15 Ophthalmic Viscoelastic Devices Market Analysis in Mexico (2021-2030)
  • Figure 16 Ophthalmic Viscoelastic Devices Market Analysis in Europe (2021-2030)
  • Figure 17 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Type (2021-2030)
  • Figure 18 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Application (2021-2030)
  • Figure 19 Ophthalmic Viscoelastic Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Ophthalmic Viscoelastic Devices Market Analysis in France (2021-2030)
  • Figure 22 Ophthalmic Viscoelastic Devices Market Analysis in Germany (2021-2030)
  • Figure 23 Ophthalmic Viscoelastic Devices Market Analysis in UK (2021-2030)
  • Figure 24 Ophthalmic Viscoelastic Devices Market Analysis in Italy (2021-2030)
  • Figure 25 Ophthalmic Viscoelastic Devices Market Analysis in Spain (2021-2030)
  • Figure 26 Ophthalmic Viscoelastic Devices Market Analysis in Russia (2021-2030)
  • Figure 27 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific (2021-2030)
  • Figure 29 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Type (2021-2030)
  • Figure 30 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Application (2021-2030)
  • Figure 31 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by End User (2021-2030)
  • Figure 32 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Country (2021-2030)
  • Figure 33 Ophthalmic Viscoelastic Devices Market Analysis in China (2021-2030)
  • Figure 34 Ophthalmic Viscoelastic Devices Market Analysis in Japan (2021-2030)
  • Figure 35 Ophthalmic Viscoelastic Devices Market Analysis in India (2021-2030)
  • Figure 36 Ophthalmic Viscoelastic Devices Market Analysis in Australia (2021-2030)
  • Figure 37 Ophthalmic Viscoelastic Devices Market Analysis in South Korea (2021-2030)
  • Figure 38 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Asia Pacific (2021-2030)
  • Figure 39 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World (2021-2030)
  • Figure 40 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Type (2021-2030)
  • Figure 41 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Application (2021-2030)
  • Figure 42 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by End User (2021-2030)
  • Figure 43 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Country (2021-2030)
  • Figure 44 Ophthalmic Viscoelastic Devices Market Analysis in Middle East (2021-2030)
  • Figure 45 Ophthalmic Viscoelastic Devices Market Analysis in Africa (2021-2030)
  • Figure 46 Ophthalmic Viscoelastic Devices Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER'S Five Force Analysis